Initiating screening at age 45 years would require an additional 10 million colonoscopies, which could potentially provide greater benefit if used instead to increase screening rates in older patients, authors of the modeling study said.
A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.
Decompensation-free survival improved in patients with cirrhosis and portal hypertension who received beta-blockers versus placebo, largely due to a decrease in ascites.
One recent study found a link between depression and diarrhea and constipation, while another found that cognitive behavioral therapy may be an effective treatment for patients with refractory irritable bowel syndrome.
The hepatitis C virus (HCV) treatment completion rate was 97% among all participants, including those actively using drugs.
Age-appropriate, up-to-date vaccination is key.
Common misconceptions about the disease can lead to missed or delayed diagnosis.
The FDA is exploring additional steps to reduce contamination rates, which were higher in postmarket surveillance studies than the agency initially anticipated.